Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)-Reference-Cited by-同舟云学术

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Published:2013-02 Issue:3 Volume:21 Page:748-765
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Fushimi Nobuhiko,Teranishi Hirotaka,Shimizu Kazuo,Yonekubo Shigeru,Ohno Kohsuke,Miyagi Takashi,Itoh Fumiaki,Shibazaki Toshihide,Tomae Masaki,Ishikawa-Takemura Yukiko,Nakabayashi Takeshi,Kamada Noboru,Yamauchi Yuji,Kobayashi Susumu,Isaji Masayuki

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. International Diabetes Federation. 2011 Guideline for Management of PostMeal Glucose in Diabetes, Brussels, Belgium.

2. Role of postprandial hyperglycemia in cardiovascular disease

3. Should Postprandial Glucose Be Measured and Treated to a Particular Target? Yes.

4. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

5. The DECODE Study Group Lancet 1999, 354, 617.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives;Journal of Medicinal Chemistry;2022-08-04

2. SGLT‐1‐specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine‐induced renal failure;Physiological Reports;2021-12

3. SGLT inhibitors as antidiabetic agents: a comprehensive review;RSC Advances;2020

4. SGLT1 inhibition boon or bane for diabetes‐associated cardiomyopathy;Fundamental & Clinical Pharmacology;2019-11-19

5. Novel synthesis of new pyrazole thioglycosides as pyrazomycin analogues;Nucleosides, Nucleotides & Nucleic Acids;2019-01-28